Patent · US Active

Liquid pharmaceutical formulations of palonosetron

US8598219B2 · kind B2 · utility

6Cited by

29References

8Claims

0Family size

Assignees

Helsinn Healthcare SA · CH
Roche Palo Alto LLC · US

Inventors

Giorgio Calderari · Rancate, CH
Daniele Bonadeo · Varese, IT
Roberta Cannella · Varese, IT
Alberto Macciocchi · Melide, CH
Andrew Miksztal · Palo Alto, US
Thomas Malefyt · Carmel Valley, US
Kathleen M. Lee · Palo Alto, US
Carmine Panuccio · Cantù, IT

Key dates

Filing date	May 23, 2013
Grant date	Dec 3, 2013
Priority date	—
Expiry date	May 23, 2033

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB65B55/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.